Idiopathic Pulmonary Fibrosis (IPF) – weathering the pandemic
Patient insights to shape development of a dCBT for IPF patients
C21 shows promise against COVID-19 where other drugs have failed
Top line data on the ATTRACT study
Interview with Ella Radvogin, Clinical Psychologist at Alex Therapeutics